Infectious complications continue to be one of the major causes of morbidity and mortality in patients with acute myeloid leukemia (AML). Several single-nucleotide polymorphisms (SNPs) of Toll-like receptors (TLRs) can affect the genetic susceptibility to infections or even sepsis. We sought to investigate the impact of different SNPs on the incidence of developing sepsis and pneumonia in patients with newly diagnosed AML following induction chemotherapy. We analyzed three SNPs in the TLR2 (Arg753Gln) and TLR4 (Asp299Gly and Thr399Ile) gene in a cohort of 155 patients with AML who received induction chemotherapy. The risk of developing sepsis and pneumonia was assessed by multiple logistic regression analyses. The presence of the TLR2 Arg753Gln polymorphism was significantly associated with pneumonia in AML patients (odds ratio (OR): 10.78; 95% confidence interval (CI): 2.0-58.23; P = 0.006). Furthermore, the cosegregating TLR4 polymorphisms Asp299Gly and Thr399Ile were independent risk factors for the development of both sepsis and pneumonia (OR: 3.55; 95% CI: 1.21-10.4, P = 0.021 and OR: 3.57, 95% CI: 1.3-9.86, P = 0.014, respectively). To our best knowledge, this study represents the first analysis demonstrating that polymorphisms of TLR2 and TLR4 influence the risk of infectious complications in patients with AML undergoing induction chemotherapy.
INTRODUCTION
The outcome of patients with acute myeloid leukemia (AML) does not only depend on risk-adapted treatment with chemotherapy but also on allogeneic stem cell transplantation. Furthermore, the occurrence of infectious complications represents a crucial factor affecting the prognosis of AML patients. Therefore, prophylaxis and treatment of infections have an important role in the clinical management of these patients. 1 Induction chemotherapy of AML results in a long period of neutropenia that is associated with a high risk of infectious complications including common bacterial infections (e.g. catheter-associated complications or sepsis) and opportunistic infections that are usually restricted to immunocompromised patients (e.g. invasive aspergillosis). 2, 3 Sepsis and pneumonia reflect the most important infectious complications and are associated with an increased mortality after AML induction chemotherapy. This warrants novel strategies identifying patients at risk of developing sepsis and septic shock. 4, 5 The innate immune system is of fundamental importance for both the direct defense of microorganisms by induction of cellular signaling pathways to induce immune response genes, including inflammatory cytokines and the activation of the adaptive immune system. 6 Furthermore, Toll-like receptors (TLRs) have a pivotal role as pattern recognition receptors that initiate a fast response of innate immunity against numerous infectious agents. 7, 8 TLR2 and TLR4 are two of the most extensively studied TLRs to have an important role in the recognition of both bacterial and fungal pathogens. 9 Several studies have investigated the functional consequences of TLR4 single-nucleotide polymorphisms (SNPs). 10 Structural analysis of TLR4 has revealed evidence of an impaired binding to its ligands for the most frequent polymorphisms of TLR4: Asp299Gly (rs4986790) and TLR4 Thr399Ile (rs4986791). 11 In genetic association studies, the presence of TLR4 polymorphisms leads to a more severe course of sepsis in critically ill patients and results in a higher rate of Gram-negative infections in verylow-birth-weight infants. 12, 13 Importantly, there is an association of both TLR4 polymorphisms (Asp299Gly and Thr399Ile) with an increased risk of infection in patients with HIV-1 infection and low CD4 cell counts. 14 TLR4 polymorphisms seem to be important for fungal infections as it can be demonstrated both for bloodstream infections with Candida spp. and for invasive aspergillosis following allogeneic stem cell transplantation. 15, 16 Furthermore, the risk of invasive aspergillosis was demonstrated to be higher after allogeneic stem cell transplantation in patients with TLR4 polymorphisms. 16 The TLR2 polymorphism Arg753Gln (rs5743708) leads to a functional deficiency concerning heterodimerization with TLR6 resulting in a diminished activation of intracellular signaling pathways. 17 The presence of TLR2-SNPs has been associated with an increased risk of Gram-positive bacterial infections in patients after liver transplantation and with a higher probability of sepsis in critically ill patients. 18, 19 The TLR2 polymorphism Arg753Gln is also attributed to a higher risk of viral infections (cytomegalovirus and hepatitis C) after liver transplantation. 18, 20 This observation can in part be explained by failed nuclear factor-κB activation because of an impaired recognition of hepatitis C virus by altered TLR2dependent downstream signaling. 21 Only a few retrospective analyses investigate whether polymorphisms of innate immunity influence the risk of severe infections in leukemia patients including those with AML. Importantly, these studies do not demonstrate any correlation between different SNPs and important clinical events such as fungal infections or sepsis. 22, 23 Recently, we could demonstrate a relationship between functionally relevant polymorphisms of the NOD2 gene and the occurrence of Streptococcus spp. in positively tested blood stream cultures in a cohort of 131 AML patients who were treated with induction chemotherapy. 24 In this study, we hypothesize an impact of TLR2 and TLR4 SNPs on susceptibility of AML patients towards developing sepsis and pneumonia during severe neutropenia following intensive chemotherapy. Here, we present a retrospective single-center analysis of infectious complications in 155 AML patients who received induction chemotherapy after initial diagnosis.
RESULTS

Frequency of TLR2 and TLR4 polymorphisms
All 155 patients were assessed for the presence of TLR2 Arg753Gln, TLR4 Asp299Gly and TLR4 Thr399Ile polymorphisms by pyrosequencing. Supplementary Figure S1 demonstrates typical genotyping data for one of the three SNPs (TLR4 Asp299Gly).
In 10 of 155 patients (6.5%), the TLR2 Arg753Gln polymorphism was found, while 9 of these 10 patients were heterozygous and a single patient was homozygous for the SNP. In 19 of 155 patients (12.3%), both the TLR4 Asp299Gly and the TLR4 Thr399Ile polymorphisms were detected in a heterozygous state. One additional patient was tested to be heterozygous for the TLR4 Thr399Ile polymorphism only. Importantly, none of the patients investigated in this study was a carrier of both TLR2 and TLR4 SNPs. All three SNPs were in accordance with Hardy-Weinberg equillibrium (χ 2 test).
For analyses considering the impact of TLR4 polymorphisms, we focused on the comparison between patients with the wild-type genotype and tested heterozygous for the cosegregating TLR4 SNPs.
Analysis of fever episodes in AML patients
We analyzed the frequency and duration of neutropenic fever between the start of induction chemotherapy and discharge at hematopoietic recovery in all AML patients investigated in this study ( Figure 1 ). There was neither a correlation between one of these SNPs with the number of fever episodes nor an association with the duration of neutropenic fever. Nevertheless, we could demonstrate a trend concerning a putative correlation between the detection of both TLR4 SNPs and the duration of fever after induction chemotherapy. In TLR4 wild-type patients, the median fever duration was 5.5 days (0-27), whereas in patients carrying the TLR4 polymorphisms, it was 8 days (0-21), respectively (P = 0.09) ( Figure 1a ).
Impact of TLR polymorphisms on development of sepsis
Next, we were interested in determining whether one of the analyzed TLR polymorphisms was associated with the occurrence of such an important infectious complication as sepsis ( Table 1) . The isolated bloodstream pathogens are presented in Figure 1 . Duration of fever and fever episodes. Impact of TLR polymorphisms on the duration of fever (a) and the number of fever episodes (b) is demonstrated. Supplementary Table S1 . Our analyses demonstrated an increased susceptibility to sepsis for AML patients harboring a TLR2 Arg753Gln polymorphism. In detail, sepsis criteria were observed in 46% of TLR2 wild-type patients and 80% of patients with the TLR2 SNP, respectively. Despite the low number of patients carrying this TLR polymorphism, we were able to demonstrate a trend towards TLR2 Arg753Gln being an independent risk factor for the occurrence of sepsis (odds ratio (OR): 4.79; 95% confidence interval (CI): 0.98-23.33; P = 0.053).
The criteria for sepsis were fulfilled in 44% of TLR4 wild-type patients and in 74% of patients with TLR4 SNPs, respectively. The cosegregating polymorphisms of the TLR4 gene Asp299Gly and Thr399Ile occurred to be independent risk factors for the development of sepsis (OR: 3.55; 95% CI: 1.21-10.4; P = 0.021).
By logistic regression, none of the clinical characteristics (sex, subtype of AML, cytogenetic risk group, age at diagnosis, leukocyte count, percentage of blasts in peripheral blood and bone marrow) were identified as an individual risk factor or had an impact on the association between TLR2 or TLR4 polymorphisms and the development of sepsis.
Effect of TLR polymorphisms on the occurrence of pneumonia Considering the high rate of pneumonia in immunocompromised patients including those with AML, we next evaluated the impact of TLR2 and TLR4 polymorphisms on the risk of pneumonia according to the above-mentioned criteria. We compared the occurrence of pneumonia documented by new radiographic infiltrates and clinical criteria between carriers of TLR polymorphisms and patients with wild-type TLR ( Table 2 ). We can demonstrate that both patients with the TLR2 SNP Arg753Gln and those harboring the TLR4 SNPs Asp299Gly and Thr399Ile have a significant higher risk of pneumonia following induction chemotherapy of AML. In the TLR2 and TLR4 wild-type group, pneumonia was documented in~30% of patients. Importantly, in AML patients tested positive for the TLR2 or TLR4 polymorphisms, pneumonia was diagnosed in 80% and 58%, respectively. Thus, both the TLR2 SNP and the TLR4 polymorphisms were identified as independent risk factors for the occurrence of pneumonia. The association between both subgroups of TLR polymorphisms and the risk of pneumonia was again confirmed by logistic regression and calculation of ORs for TLR2 (OR: 10.78; 95% CI: 2.0-58.23, P = 0.006) and TLR4 (OR: 3.57; 95% CI: 1.3-9.86; P = 0.014).
By logistic regression analysis, it was shown that age had an impact on the association between the TLR4 polymorphisms and the occurrence of pneumonia. It could be demonstrated that the risk of pneumonia increases with age (3.4% per year) (OR: 1.034; 95% CI: 1.005-1.063; P = 0.020). All other clinical variables were not identified as risk factors for the development of pneumonia.
DISCUSSION
In this study, we raised the question whether polymorphisms of TLR2 or TLR4 are associated with the risk of developing sepsis and pneumonia in AML patients who received intensive induction chemotherapy as first-line treatment. The allele frequency of the investigated TLR2 polymorphism correlates well with data previously published by other groups. In detail, one analysis of Caucasian patients from Germany could detect the TLR2 Arg753Gln SNP at a comparable level as demonstrated in this study. 25 Data published on the frequency of the two TLR4 polymorphisms studied (Asp299Gly and Thr399Ile) are heterogeneous. Nevertheless, several groups could detect these TLR4 SNPs at a level similar to our results. 12, 26 We could demonstrate a significant correlation between harboring TLR2 (Arg753Gln) or TLR4 (Asp299Gly and Thr399Ile) SNPs compared with wild-type patients and the development of sepsis and pneumonia in AML patients who underwent induction chemotherapy.
There are several aspects contributing to the persistent challenge of AML treatment. Although resistance to or relapse after chemotherapy regimens and relapse after allogeneic stem cell transplantation represent the most serious problems, the occurrence of severe infectious complications can also profoundly affect prognosis of AML patients. Long-lasting neutropenia following intensive chemotherapy can be considered as the main risk factor for bacterial and fungal infections in AML patients.
Owing to the fact that all patients with neutropenic fever fulfill the criteria of systemic inflammatory response syndrome, there is a high rate of sepsis as defined by the current clinical criteria. 27 Recommendations concerning primary prophylaxis of bacterial and fungal infections in AML patients undergoing induction chemotherapy, therefore, consist of a flurochinolone (e.g. ciprofloxacin) and an azole (e.g. posaconazole).
Genetic variations of the pathogen recognition system are supposed to be responsible for individual differences concerning the response to infectious stimuli. In detail, a series of SNPs affecting key molecules of innate immunity including surface molecules such as TLR2, TLR4, TLR5 and different variants of the mannose-binding lectin 2 or intracellular downstream molecules as the IL-1 receptor-associated kinase and the TIR-domaincontaining adaptor protein have been attributed with an increased risk of infections. [28] [29] [30] [31] Inconsistent studies have been reported about the influence of polymorphisms of the innate immune system on the course of infectious complication in hematological and non-hematological diseases.
In a cohort of 199 HIV patients, Papadopoulos et al. 14 could demonstrate an association between the two cosegregating TLR4 polymorphisms and the occurrence of serious infections in those patients. In addition, there was an increased risk of pulmonary aspergillosis after allogeneic stem cell transplantation in the presence of TLR4 polymorphisms. 16 Other investigators failed to Abbreviations: AML, acute myeloid leukemia; CI, confidence interval; SNP, single-nucleotide polymorphism; TLR, Toll-like receptor. demonstrate a significant association between the three investigated polymorphisms and infectious events. 10 In our study, the relevant impact of TLR4 polymorphisms on the susceptibility of AML patients to develop sepsis might in part be explained by the expression of TLR4 on intestinal epithelial cells, which is still a matter of debate. 32 Furthermore, it can be hypothesized that very low numbers of host immune cells can still circulate or reside in organs with important barrier functions (e.g. gastrointestinal tract). Another important aspect is reflected by the physiological function of gut microflora that has a pivotal role for the maintenance of intestinal host defense by inducing TLR4 expression. 33 In consideration of necessary antibiotic prophylaxis in AML patients, TLR4 downregulation, functional impairment due to TLR4 polymorphisms and toxicity-related damage of gut epithelial cells may contribute and synergize with respect to the risk of sepsis in AML patients.
We could show that the TLR2 Arg753Gln polymorphism is strongly associated with a higher risk of pneumonia during induction chemotherapy. We are aware that these results are based on a rather low number of patients tested positive for this TLR2 SNP resulting in a wide 95% CI. Furthermore, we decided to merge all kinds of pneumonia independent of its proven or probable etiology according to clinical and radiographic findings. In our cohort, the risk of pneumonia is significantly increased with the TLR2 Arg753Gln polymorphism compared with AML patients without this SNP. Furthermore, we could demonstrate a significantly higher incidence of pneumonia in those patients who harbor the cosegregating TLR4 polymorphisms. Both TLR2 and TLR4 are important pathogen recognition receptors that are also expressed on pulmonary epithelia cells. Interestingly, TLR2 expression is upregulated in type I alveolar epithelial cells during bacterial pneumonia. The resulting role of these epithelial cells thus contributing to innate immunity can be interpreted independent of circulating blood cells and seems to have a pivotal role for local defense during respiratory infections. 34 Furthermore, almost one decade ago, TLR4 has been shown to have a pivotal role for immune response in a bacterial pneumonia in a mouse model. 35 Thus, functionally relevant polymorphisms of the investigated TLRs might result in an increased risk of pneumonia. This hypothesis is strongly supported by recently published clinical data. In detail, there was an increased mortality from pneumonia in elderly patients depending on the extent of TLR2 and TLR4 downregulation. 36 In this study, we also investigated the occurrence of neutropenic fever as a clinical parameter with respect to a potential correlation with one of the analyzed TLR polymorphisms. Despite fever being a very unspecific symptom that can be caused by several factors, the occurrence of neutropenic fever is of special importance and generally considered to be mediated by an underlying infection. We could not demonstrate significant differences for SNPs of either TLRs concerning the number of fever episodes or the duration of fever. We speculate that for the occurrence of neutropenic fever, only a minimal immune response mediated by the production of proinflammatory cytokines independent of TLR SNPs might be necessary.
To our knowledge, this study represents the first analysis demonstrating that TLR2 and TLR4 polymorphisms influence the risk of developing pneumonia and sepsis in patients with acute myeloid leukemia undergoing induction chemotherapy. The broad spectrum of functionally relevant SNPs of innate immune system might allow further insights into individual risk factors regarding severe infectious complications in hematological patients. Further studies are needed to elucidate such molecular markers as SNPs of innate immunity to redefine strategies of antimicrobial prophylaxis or to adjust pharmacological treatment of infections in immunocompromised patients.
PATIENTS AND METHODS Patients
One hundred and fifty-five white patients (74 male, 81 female; median age 57 years, range 19-78 years) from Germany with newly diagnosed AML were included in this retrospective analysis. All patients enrolled in this study underwent curative-intent induction chemotherapy at the Department of Internal Medicine II (Hematology and Medical Oncology) at Jena University Hospital, Germany, between 2000 and 2013. The study was approved by the institutional review board. All patients received intensive induction chemotherapy according to one of the following protocols of the Ostdeutsche Studiengruppe für Hämatologie und Onkologie (OSHO): AML96 or AML2002 protocol containing idarubicine for patients up to 60 years old and AML97 or AML2004 protocol containing mitoxantrone for elderly patients. 37, 38 For antibiotic and anti-fungal prophylaxis, all patients received either trimethoprim-sulfamethoxazole or ciprofloxacin and fluconazole or posaconazole, respectively.
Patients with acute promyelocytic leukemia were excluded from this study. Clinical characteristics of all investigated AML patients are demonstrated in Table 3 . The observational period was the same for all subgroups as defined by the interval between the start of induction chemotherapy and the discharge from hospital after hematological reconstitution. Three patients died from infectious complications after induction chemotherapy including two patients within 30 days. Another patient who had a long-lasting neutropenia without evidence of relapse died at day 84 after induction chemotherapy.
Cytogenetic analyses
Karyotype was determined at initial diagnosis of AML by G-banding of at least 20 metaphases. In four patients, cytogenetic analysis could not be performed owing to the poor quality of the material. Bone marrow or peripheral blood cells were karyotyped according to the International System for Human Cytogenetic Nomenclature. 39 Cytogenetic risk groups were attributed according to established recommendations. 40 
Diagnostic criteria of infectious events
Clinical events such as sepsis, systemic inflammatory response syndrome and fever of unknown origin were defined according to the guidelines published by the German Sepsis Society in 2010. 27 Fever was defined as a single body temperature of at least 38.3°C or at least 38.0°C sustaining over a 1-h period. Fever events within an interval of 72 h were defined as a single episode. Pneumonia was defined as a new infiltrate on chest radiograph (X-ray and/or computer tomography) in combination with at least two of the following criteria: cough, sputum production, temperature 438°C or o35°C and auscultatory findings consistent with pneumonia. 
Analysis of TLR polymorphisms
Genotyping of TLR2 Arg753Gln (R753Q, rs5743708), TLR4 Asp299Gly (D299G, rs4986790) and TLR4 Thr399Ile (T399I, rs4986791) was performed by pyrosequencing. Briefly, genomic DNA was isolated from peripheral blood or bone marrow samples using the QIAamp Blood Mini Kit according to the manufacturer's instructions (Qiagen, Hilden, Germany). PCR and sequencing primer were designed using the PSQ assay design tool: TLR4 Asp299Gly forward primer, 3′-CGTTTGGTTCTGGGAGAATTTA-5′ and reverse primer: 3′-Biotin-ATGTGGGAAACTGTCCAAATTTAC-5′; TLR4 Thr399Ile forward primer, 3-′ACAAAGGTGGGAATGCTTTTTCAG-5′ and reverse primer: 3′-Biotin-GCCCAAGAAGTTTGAACTCATGGT-5′; TLR2 Arg753Gln forward primer, 3′-Biotin-GGTGCAAGTATGAACTGGACTTCT-5′ and reverse primer 3′-GGCCACTCCAGGTAGGTCTT-5′. One hundred nanograms of genomic DNA was amplified using the following cycling conditions for both PCR of TLR4 (Asp299Gly, Thr399Ile): 95°C for 5 min, 35 cycles of 92°C for 30 s, 60°C for 30 s and 72°C for 30 s followed by a final extension of 72°C for 5 min. The PCR protocol for TLR2 amplification was the same as for TLR4 except that annealing temperature was 63°C. Primer concentrations were 600 nM each at a final volume of 25 μl with 1.5 mM MgCl 2 . The pyrosequencing run was performed with PyroMark Q96 ID (Qiagen) by using Pyromark Gold Q96 Reagents (Qiagen) according to the manufacturer's instructions. Sequencing primers (TLR4 Asp299Gly: 3′-ATA CTTAGACTACTACCTCG-5; TLR4 Thr399Ile: 3′-CAAAGTGATTTTGGGAC-5; TLR2 Arg753Gln: 3′-TCTTGGTGTTCATTATCTTC-5) were used at 400 nM final concentration.
Statistics
For statistical calculations, the SPSS software package, version 22 (SPSS, Chicago, IL, USA) was used. Quantitative characteristics were expressed by their median value. Multiple logistic regression analyses to evaluate the association of polymorphism with the occurrence of sepsis or pneumonia adjusted for clinical variables were applied. Clinical variables included sex, subtype of AML, cytogenetic risk group, age at diagnosis, leukocyte count, percentage of blasts in peripheral blood and bone marrow. The analyses were performed using forward stepwise logistic regression. Results of the stepwise logistic regression analyses are presented as OR with 95% CI and corresponding P-values. The level of significance was set at 5%. Non-normally distributed values (fever episodes, fever duration) were calculated by Mann-Whitney U-test. A two-tailed P ⩽ 0.05 was considered to be significant.
